Search
Remarks by Dr. Sharpless at the FDA Public Hearing on Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds - 05/31/2019
… Thank you for joining FDA today for this public hearing titled “Scientific Data and Information About … attendees, and those unable to participate in today’s hearing – to submit comments to our docket on this topic, … group to address these data gaps specifically. You’ll be hearing more from this group in the months to come. FDA is …
Remarks by Lauren Silvis, Chief of Staff, to the Consumer Health Products Association Regulatory, Scientific, and Quality Conference - 05/21/2019
… the DFL and labeling are not sufficient. We’re open to hearing from sponsors who want to pursue this approach in the … the regulatory path forward, FDA is holding a public hearing on May 31 to obtain additional scientific data and … related to cannabis and cannabis-derived compounds. This hearing is expected to be an important step in our continued …
Final All Hands Meeting with Dr. Gottlieb - 04/04/2019
… times in the past two years. The only major Congressional hearing where I didn’t testify was the one hearing on OTC drug reform where Janet Woodcock told me I …
Remarks by Commissioner Califf to the 2022 FDLI Annual Conference - 06/14/2022
Remarks by FDA Commissioner Robert M. Califf to the Coalition for Health AI (CHAI) - 03/05/2024
… data as a “one-off” activity. Not surprisingly, I’m hearing that the “effectiveness” metric being used by health …
Remarks by Anna Abram to the Biocom Celebration of Life Dinner - 11/21/2019
… and interchangeable insulin products. We held a public hearing to seek public input on the topic and we have been …
Remarks by Dr. Susan Mayne, Director of the Center for Food Safety and Applied Nutrition at the Food and Drug Law Institutes 2023 Annual Conference - 05/17/2023
… for this during my tenure which included testifying in a hearing on the Hill about this topic. Second, the FDA is …